Welcome to our dedicated page for Curaleaf Hldgs SEC filings (Ticker: CURLF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Curaleaf Holdings, Inc. files foreign issuer reports that document its cannabis operations, financial statements, governance actions, and capital-structure matters. Recent Form 6-K filings include interim consolidated financial statements, management discussion and analysis, CEO and CFO certifications, press releases, and documents incorporated by reference into a Form F-10 registration statement.
The filing record covers auditor changes, annual and special meeting matters, director elections, auditor appointment, equity incentive plan items, multiple voting share provisions, subordinate voting shares, normal course issuer bid activity, automatic securities disposition plans, and completed acquisition disclosures for Four 20 Pharma.
Curaleaf Holdings, Inc. filed a Form 6-K as a foreign private issuer to share a press release about its upcoming first quarter 2026 results. The company plans to report financial and operational results for the quarter ended March 31, 2026 after market close on May 5, 2026.
Management will host a conference call and webcast on May 5, 2026 at 5:00 p.m. ET, including prepared remarks and a question-and-answer session. The filing also provides dial-in details, replay information available until May 12, 2026, and links to Curaleaf’s investor relations resources.
Curaleaf Holdings, Inc. is issuing US$500,000,000 of 11.50% Senior Secured Notes due February 18, 2029 under a Fourth Supplemental Indenture. The notes pay 11.50% interest semi-annually in U.S. dollars, starting August 18, 2026, and may be issued in additional tranches on the same terms.
Before August 18, 2027, Curaleaf can redeem up to 35% of the notes at par plus 100% of the coupon and accrued interest using net cash from qualifying equity offerings. From August 18, 2027, the notes are redeemable at 105.750% of principal, and at 100.000% from February 18, 2028 onward, plus accrued interest.
Curaleaf Holdings, Inc. filed its Annual Report on Form 40-F for the fiscal year ended December 31, 2025, reporting 678,504,043 Subordinate Voting Shares outstanding as of that date. Management concluded that the Company’s disclosure controls and internal control over financial reporting were effective as of December 31, 2025, and the report incorporates audited consolidated financial statements and MD&A as exhibits.
The filing names PKF O'Connor Davies, LLP and related PKF firms as independent auditors, lists aggregate auditor fees for 2025 and 2024, and includes an exhibit index with the Annual Information Form, audited financials, officer certifications and an earnings release dated February 26, 2026.
Curaleaf Holdings has closed a private placement of US$500 million aggregate principal amount of 11.5% senior secured notes due February 18, 2029. The notes were issued at 100% of face value and are payable semi-annually until maturity, unless earlier redeemed or purchased.
The company redeemed its previously outstanding US$475 million senior secured notes due December 15, 2026, extending its debt maturity profile while raising additional capital. Curaleaf plans to use net proceeds to support global growth initiatives and to pay transaction fees and expenses, under an indenture that also permits additional note issuance and up to US$100 million of senior bank financing.
Curaleaf Holdings, Inc. is postponing its previously planned special shareholder meeting to approve a proposed arrangement that includes continuing the company out of British Columbia and domestication in Delaware in the United States. The special meeting will now be combined with Curaleaf’s annual general meeting, expected in the second quarter of 2026.
The company believes holding a combined annual and special meeting will encourage greater shareholder participation, streamline approvals and use resources more efficiently. Curaleaf plans to announce the new meeting date later and will send shareholders an Information Circular, which will also be filed on SEDAR+ and with the SEC.
Curaleaf Holdings, Inc. has scheduled the release of its fourth quarter and full year 2025 financial and operating results for after market close on February 26, 2026. Management will discuss the results on a conference call and webcast that day at 5:00 p.m. ET, followed by a question-and-answer session.
Curaleaf Holdings, Inc. released preliminary, unaudited results for Q4 2025 and announced strategic exits from its hemp business and the state of Missouri. Net revenue for Q4 2025 excluding these discontinued operations is expected to be at least $330 million, implying approximately 4% sequential growth from Q3 2025 net revenue of $317.8 million and about 1% growth versus Q4 2024 net revenue of $327.8 million, above the prior guidance of low single digit growth.
Fourth quarter adjusted gross profit margin excluding the discontinued businesses is anticipated to be about 48.5%, in line with Q4 2024, and full year 2025 adjusted gross margin is expected to be around 50%. Management is discontinuing the hemp division following U.S. federal legislation reducing permitted hemp-derived THC content to 0.3% and exiting Missouri due to sub-scale operations; together these units contributed roughly $2 million of revenue across Q3 and Q4 2025. The company also highlighted plans to complete refinancing of its senior secured notes due December 2026 and expects to release full Q4 and full-year 2025 results by early March.